Tumor-targeted drug delivery via
chemotherapy is very effective
on cancer treatment. For potential anticancer agent such as Camptothecin
(CPT), high chemotherapeutic efficacy and accurate tumor targeting
are equally crucial. Inspired by special CD44 binding capability from
hyaluronic acid (HA), in this study, novel HA-coated CPT nanocrystals
were successfully prepared by an antisolvent precipitation method
for tumor-targeted delivery of hydrophobic drug CPT. These HA-coated
CPT nanocrystals demonstrated high drug loading efficiency, improved
aqueous dispersion, prolonged circulation, and enhanced stability
resulting from their nanoscaled sizes and hydrophilic HA layer. Moreover,
as compared to crude CPT and naked CPT nanocrystals, HA-coated CPT
nanocrystals displayed dramatically enhanced in vitro anticancer activity,
apoptosis-inducing potency against CD44 overexpressed cancer cells,
and lower toxic effect toward normal cells due to pH-responsive drug
release behavior and specific HA-CD44 mediated endocytosis. Additionally,
HA-coated CPT nanocrystals performed fairly better antimigration activity
and biocompatibility. The possible molecular mechanism regarding this
novel drug formulation might be linked to intrinsic mitochondria-mediated
apoptosis by an increase of Bax to Bcl-2 ratio and upregulation of
P53. Consequently, HA-coated CPT nanocrystals are expected to be an
effective nanoplatform in drug delivery for cancer therapy.